The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual-participant data from 15 international studies.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
03 2023
Historique:
received: 19 12 2021
accepted: 04 08 2022
pubmed: 23 8 2022
medline: 7 2 2023
entrez: 22 8 2022
Statut: ppublish

Résumé

To synthesize international findings on the alcohol-dementia relationship, including representation from low- and middle-income countries. Individual participant data meta-analysis of 15 prospective epidemiological cohort studies from countries situated in six continents. Cox regression investigated the dementia risk associated with alcohol use in older adults aged over 60 years. Additional analyses assessed the alcohol-dementia relationship in the sample stratified by sex and by continent. Participants included 24 478 community dwelling individuals without a history of dementia at baseline and at least one follow-up dementia assessment. The main outcome measure was all-cause dementia as determined by clinical interview. At baseline, the mean age across studies was 71.8 (standard deviation = 7.5, range = 60-102 years), 14 260 (58.3%) were female and 13 269 (54.2%) were current drinkers. During 151 636 person-years of follow-up, there were 2124 incident cases of dementia (14.0 per 1000 person-years). When compared with abstainers, the risk for dementia was lower in occasional [hazard ratio (HR) = 0.78; 95% confidence interval (CI) = 0.68-0.89], light-moderate (HR = 0.78; 95% CI = 0.70-0.87) and moderate-heavy drinkers (HR = 0.62; 95% CI = 0.51-0.77). There was no evidence of differences between life-time abstainers and former drinkers in terms of dementia risk (HR = 0.98; 95% CI = 0.81-1.18). In dose-response analyses, moderate drinking up to 40 g/day was associated with a lower risk of dementia when compared with lif-time abstaining. Among current drinkers, there was no consistent evidence for differences in terms of dementia risk. Results were similar when the sample was stratified by sex. When analysed at the continent level, there was considerable heterogeneity in the alcohol-dementia relationship. Abstinence from alcohol appears to be associated with an increased risk for all-cause dementia. Among current drinkers, there appears to be no consistent evidence to suggest that the amount of alcohol consumed in later life is associated with dementia risk.

Identifiants

pubmed: 35993434
doi: 10.1111/add.16035
pmc: PMC9898084
mid: NIHMS1831401
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Meta-Analysis Journal Article Review Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

412-424

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : RF1 AG057531
Pays : United States

Informations de copyright

© 2022 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

J Am Geriatr Soc. 2003 Feb;51(2):169-77
pubmed: 12558712
Lancet Public Health. 2022 Feb;7(2):e105-e125
pubmed: 34998485
Sci Rep. 2018 Feb 2;8(1):2246
pubmed: 29396480
Evid Based Ment Health. 2018 Feb;21(1):12-15
pubmed: 29273599
Int Psychogeriatr. 2008 Apr;20(2):394-405
pubmed: 17559708
J Stud Alcohol Drugs. 2016 Mar;77(2):185-98
pubmed: 26997174
N Engl J Med. 2016 Feb 11;374(6):523-32
pubmed: 26863354
Eur J Epidemiol. 2015 Sep;30(9):1049-56
pubmed: 25968174
J Mol Cell Cardiol. 2012 Jan;52(1):93-104
pubmed: 22041278
Eur Heart J. 2022 Sep 7;43(34):3258-3269
pubmed: 34661640
Int Psychogeriatr. 2010 Dec;22(8):1248-64
pubmed: 20637138
Addiction. 2020 Aug;115(8):1580-1589
pubmed: 32112474
Alzheimer Dis Assoc Disord. 2012 Oct-Dec;26(4):335-43
pubmed: 22156756
Curr Nutr Rep. 2019 Sep;8(3):222-229
pubmed: 30895470
Lancet Neurol. 2018 Nov;17(11):1006-1015
pubmed: 30244829
Curr Opin Psychiatry. 2021 Mar 1;34(2):165-170
pubmed: 33394727
Int J Epidemiol. 2006 Dec;35(6):1570-8
pubmed: 17148467
BMJ. 2018 Aug 1;362:k2927
pubmed: 30068508
Exp Ther Med. 2017 Aug;14(2):1433-1440
pubmed: 28810607
Int Rev Neurobiol. 2019;148:39-78
pubmed: 31733667
Br J Psychiatry. 2001 Sep;179:250-4
pubmed: 11532803
BMJ Glob Health. 2020 Apr 16;5(4):e001958
pubmed: 32377401
Stat Med. 2009 Mar 30;28(7):1067-92
pubmed: 19222086
Alzheimers Res Ther. 2019 Jan 5;11(1):1
pubmed: 30611304
Int J Epidemiol. 2012 Aug;41(4):951-60
pubmed: 21349904
Sci Rep. 2019 Dec 9;9(1):18651
pubmed: 31819151
Eur J Epidemiol. 2019 Feb;34(2):191-209
pubmed: 30421322
Springerplus. 2014 Jul 03;3:338
pubmed: 25045613
BMJ. 2017 Jun 6;357:j2353
pubmed: 28588063
PLoS Med. 2020 Feb 25;17(2):e1003022
pubmed: 32097439
Lancet Public Health. 2018 Mar;3(3):e124-e132
pubmed: 29475810
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Addiction. 2023 Mar;118(3):412-424
pubmed: 35993434
BMJ. 2010 Aug 05;341:c3885
pubmed: 20688841
J Alzheimers Dis. 2019;70(s1):S165-S186
pubmed: 31306123
Psychiatry Investig. 2018 Aug;15(8):767-774
pubmed: 30086611
BMC Neurol. 2013 Nov 06;13:165
pubmed: 24195705
Neuroepidemiology. 2014;43(1):9-14
pubmed: 24993387
Int J Geriatr Psychiatry. 2009 Nov;24(11):1277-84
pubmed: 19340894

Auteurs

Louise Mewton (L)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.

Rachel Visontay (R)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.

Nicholas Hoy (N)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.

Darren M Lipnicki (DM)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.

Matthew Sunderland (M)

Neuropsychiatric Institute, The Prince of Wales Hospital, Sydney, Australia.

Richard B Lipton (RB)

The Matilda Centre for Mental Health and Substance Use, University of Sydney, Sydney, Australia.
Saul R. Korey, Department of Neurology, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA.
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA.

Maëlenn Guerchet (M)

Department of Psychiatry and Behavioral Medicine, Albert Einstein College of Medicine, Yeshiva University, New York, NY, USA.

Karen Ritchie (K)

Limoges University, CHU Limoges, EpiMaCT, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.
Neuropsychiatry, Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France.
Université de Montpellier, Montpellier, France.

Jenna Najar (J)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AGECAP) at the University of Gothenburg, Mölndal, Sweden.

Nikolaos Scarmeas (N)

Region Västra Götaland, Sahlgrenska University Hospital, Psychiatry, Cognition and Old Age Psychiatry Clinic, Gothenburg, Sweden.
Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Ki-Woong Kim (KW)

Department of Neurology, Columbia University, New York, NY, USA.
Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, South Korea.
Department of Psychiatry, College of Medicine, Seoul National University, Seoul, South Korea.

Steffi Riedel Heller (S)

Department of Brain and Cognitive Sciences, Seoul National University, Seoul, South Korea.

Martin van Boxtel (M)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.

Erin Jacobsen (E)

School for Mental Health and Neuroscience/Alzheimer Centrum Limburg, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.

Henry Brodaty (H)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.

Kaarin J Anstey (KJ)

Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
School of Psychology, University of New South Wales, Sydney, Australia.
Neuroscience Research Australia, University of New South Wales, Sydney, Australia.

Mary Haan (M)

Centre for Research on Ageing, Health and Wellbeing, Australian National University, Canberra, Australia.

Marcia Scazufca (M)

Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA, USA.

Elena Lobo (E)

LIM-23, Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Department of Preventive Medicine and Public Health, Universidad de Zaragoza, Zaragoza, Spain.
Instituto de Investigacion Sanitaria Aragon, Zaragoza, Spain.

Perminder S Sachdev (PS)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Ministry of Science and Innovation, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH